Vibe Technologies recall
This article was originally published in The Gray Sheet
Executive Summary
Recall initiated Oct. 1 of Vibe Technologies' Vibrational Integrated Bio-photonic Energizer (VIBE) multi-frequency electromagnetic field generator is Class I, FDA says Oct. 31. The firm claims the device can treat or cure cancer, depression, infection and pain. However, it has not been approved by FDA. The company warns customers to stop using the device. The recall follows an April 11 warning letter from FDA for marketing the unapproved system
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.